Luna, Anaskie Kassilda M.
HRN: 24-44-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2024
CEFUROXIME 750MG (VIAL)
01/18/2024
01/24/2024
IV
750mg
Q8
URTi
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes